Rhea-AI Summary
Abattis Bioceuticals Corp. (OTC: ATTBF) announced progress in various legal and regulatory matters. The British Columbia Securities Commission (BCSC) has concluded its review of the company’s financial statements for FY2018 and FY2019, allowing Abattis to file its remaining financial disclosures. Additionally, a proposed class action lawsuit against the company has been discontinued without a monetary settlement. These developments mark a significant step towards lifting the cease trade order (CTO) imposed in 2019 and resuming trading on the Canadian Stock Exchange.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
42.46%
Tags
FAQ
What is the current stock price of ABATTIS BIOCEUTICALS (ATTBF)?
ABATTIS BIOCEUTICALS (ATTBF) last closed at $0.000001.
What is the market cap of ABATTIS BIOCEUTICALS (ATTBF)?
The market cap of ABATTIS BIOCEUTICALS (ATTBF) is approximately $4.7M.